Ocumension Therapeutics (HKG:1477)
Hong Kong
· Delayed Price · Currency is HKD 7.50
+0.05 (0.67%)
Apr 29, 2026, 4:08 PM HKT
Ocumension Therapeutics Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Net Income | - | -268.27 | -379.79 | -402.64 | -259.99 | Upgrade
|
| Depreciation & Amortization | - | 88.61 | 57.54 | 40.46 | 13.9 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | -3.18 | 3.18 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -0.29 | -1.16 | -1.25 | -125.78 | Upgrade
|
| Loss (Gain) on Equity Investments | - | - | - | - | 13.33 | Upgrade
|
| Stock-Based Compensation | - | 84.63 | 139.73 | 218.79 | 188.12 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 0.65 | 0.35 | 0.68 | - | Upgrade
|
| Other Operating Activities | - | -22.34 | -24.57 | -47 | 9.07 | Upgrade
|
| Change in Accounts Receivable | - | -38.93 | -7.65 | -33.28 | -31.15 | Upgrade
|
| Change in Inventory | - | -13.05 | -13 | -19.11 | -1.97 | Upgrade
|
| Change in Accounts Payable | - | -11.34 | 49.57 | 34.42 | -2.39 | Upgrade
|
| Change in Unearned Revenue | - | 1.5 | - | 30.09 | - | Upgrade
|
| Change in Other Net Operating Assets | - | - | 4.25 | -25 | - | Upgrade
|
| Operating Cash Flow | - | -178.83 | -177.93 | -200.66 | -196.85 | Upgrade
|
| Capital Expenditures | - | -47.1 | -80.91 | -115.81 | -195.37 | Upgrade
|
| Sale (Purchase) of Intangibles | - | -183.05 | -280.96 | -194.19 | -469.44 | Upgrade
|
| Investment in Securities | - | 470.46 | 53.22 | 522.86 | -697.79 | Upgrade
|
| Other Investing Activities | - | 35.6 | 48.86 | 16.29 | 17.31 | Upgrade
|
| Investing Cash Flow | - | 275.91 | -259.78 | 229.15 | -1,345 | Upgrade
|
| Long-Term Debt Issued | - | 46.55 | 120 | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -163.5 | -14.25 | -9.15 | -3.82 | Upgrade
|
| Total Debt Repaid | - | -163.5 | -14.25 | -9.15 | -3.82 | Upgrade
|
| Net Debt Issued (Repaid) | - | -116.95 | 105.75 | -9.15 | -3.82 | Upgrade
|
| Issuance of Common Stock | - | 0.98 | 5.6 | 12.72 | 684.73 | Upgrade
|
| Repurchase of Common Stock | - | -95.57 | -1.46 | -11 | -1.39 | Upgrade
|
| Other Financing Activities | - | -2.25 | -1.22 | -1.79 | -10.68 | Upgrade
|
| Financing Cash Flow | - | -213.79 | 108.66 | -9.22 | 668.85 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 3.07 | 1.84 | 25.56 | -35.81 | Upgrade
|
| Net Cash Flow | - | -113.63 | -327.21 | 44.83 | -909.1 | Upgrade
|
| Free Cash Flow | - | -225.92 | -258.84 | -316.47 | -392.22 | Upgrade
|
| Free Cash Flow Margin | - | -54.14% | -105.06% | -199.09% | -698.57% | Upgrade
|
| Free Cash Flow Per Share | - | -0.33 | -0.40 | -0.50 | -0.65 | Upgrade
|
| Cash Interest Paid | - | 2.25 | 1.22 | 1.79 | 0.57 | Upgrade
|
| Cash Income Tax Paid | - | 0.32 | -0.03 | 0.41 | - | Upgrade
|
| Levered Free Cash Flow | - | -344.38 | -480.3 | -404.46 | -580.44 | Upgrade
|
| Unlevered Free Cash Flow | - | -343.03 | -479.47 | -403.33 | -580.09 | Upgrade
|
| Change in Working Capital | - | -61.82 | 33.15 | -12.88 | -35.5 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.